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Abstract
This viewpoint is a continuation of the debate on the early intervention movement in psychiatry. The criticisms of Malhi
and colleagues have generated some fundamental questions about the priorities of the early intervention movement and
the need for further work. In particular, the summons sent to neuroscience need to be more specific in the near future.
We may be doing well with what we have, but more directed efforts are needed to purposefully seek what we do not.
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Malhi et al. (2020) raise a sharp criticism of the prevailing model of early
intervention (EI) in psychiatry. Their
main disapproval is that the EI movement seems to put the cart before the
horse. They contend that the early
intervention idea was ahead of its
time for psychiatry; it gathered
momentum much earlier before specific interventions for the early phase
of illness would become available. As
a result, existing interventions offered
at later stages of illness have been
‘transposed’, in their words, to an
earlier stage. This, as they argue, cannot be considered as early intervention in the true sense.
Malhi et al.’s (2017, 2021) continuous criticism may come across as ‘dirt
throwing’ to many of us practising
early intervention especially in psychosis. One of the concerns they raise
in their recent commentary is on the
use of antipsychotics before the onset
of a conventionally defined psychotic
episode (Malhi et al., 2020). Contrary
to their concern, and as pointed out
by Woods et al. (2020), this is not the
recommended practice at ‘high-risk’
or early psychosis clinics. These programmes do not advocate for inappropriate use of antipsychotics; in

fact, the existence of such clinics
indeed promotes more appropriate
use of antipsychotics for most
patients. In fact, the early intervention
approach has contributed to a healthy
scepticism regarding the length of
antipsychotic treatment (Murray
et al., 2016). This partly stems from
the clearance of the clinical illusion of
a relentless progression in psychosis
(Zipursky et al., 2013).
One undeniable issue that emerges
from Malhi’s arguments is the lack of
purpose-built means for early intervention. They argue that this issue has
been glossed over for too long, especially as the field contented with using
the less than satisfactory interventions of the bygone era, but now at an
earlier date in the illness trajectory.
This has had one unforeseen consequence in their eyes: the diminution
of efforts to ‘fact-check’ early interventions (Malhi et al., 2020). On this
issue, Malhi and colleagues stand on
firmer ground.

The headless horseman
To date, the neuroscientific understanding of the effects of early intervention remains minimal. In fact, the
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‘neurobiological case’ for EI is often
made repeatedly on the basis that EI
will reduce progressive brain changes
that may otherwise occur (‘active psychosis .... in effect, “bad for the brain”
in that it reflected an underlying
pathophysiologic process that was
progressive unless alleviated by treatment’, from Lieberman et al., 2019).
Despite more than 100 years of pursuit, these deleterious progressive
brain changes remain the Headless
Horseman when treating early psychosis. No one has seen him for sure;
but everyone is scared of him and
warn others. To make the matters
worse, progressive changes may in
fact occur secondary to antipsychotic
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medications, at least in some patients
(Ho et al., 2011).
Thus, so far, invoking neuroscientific
basis for early intervention has only
been a form of well-intended scare tactics. It is important to establish whether
the horseman exists, and if indeed, he is
headless as the folklore goes. Structural
changes are temporally constrained to
the early post-onset phase, spatially
constrained to selected regions and
include both tissue loss and tissue gain
(Palaniyappan, 2017). A substantial
amount of these changes could indeed
be compensatory, representing a reorganisation response to the illness, as
argued elsewhere (Palaniyappan and
Sukumar, 2020). Thus, the horseman,
even if he exists, may not intend the
imagined harm.

Why do latecomers to
the clinic get penalised?
One important argument for EI is that
latecomers to the clinic do not fare well
upon treatment (Drake et al., 2020). EI
movement has been focussed on helping
people to seek help early, instead of
leaving it too late. Promoting early helpseeking is a pragmatic step for any illness
that does not resolve spontaneously,
and in the case of psychosis may even
reduce mortality (Anderson et al., 2018).
But why are latecomers less responsive
to the same treatment that works better for the more punctual help-seekers?
What is the mechanistic basis of this
penalty levied on latecomers? This question has to be at the heart of the neuroscience of early intervention, but to date
has not been given its due importance
(Palaniyappan and Krishnadas, 2020).
The answers for this question will move
us closer to discovering approaches that
are true to the spirit of secondary prevention. Instead, the focus seems to be
on turning what started as a targeted
secondary prevention to an all-encompassing primary prevention movement
(Mei et al., 2020). To this end, demonstrating brain-based differences among
the presumed stages of the broadly
defined mental illnesses is being seen as
an important next step (Shah et al.,
2020).
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The three epochs of
EI – improving awareness,
facilitating access and
informing action
The first epoch of EI movement
focussed on improving awareness on
intervening early for psychosis. The
second focussed on improving access
to the youth, irrespective of the diagnostic status. The third, from now,
needs to focus on discovering appropriate means to provide the so far
promised early intervention. This
requires being sceptical of the brainlevel benefits of early intervention as
it is practised currently, that is, asking
what good it is to the brain if the currently available interventions are
offered during the lead-time gained
from early detection. The answer will
likely be irrelevant for those who
already receive the remarkable social
and psychological benefits of early
intervention, but very pressing for
two other groups – those who continue to come late and those who
continue to suffer despite being punctual. These two groups make up too
large a number for us to neglect.
Declaration of Conflicting
Interests
The author(s) declared the following
potential conflicts of interest with respect
to the research, authorship, and/or publication of this article: L.P. receives book
royalties from Oxford University Press
and income from the SPMM MRCPsych
course. In the last 5 years, his or his
spousal pension funds held shares of Shire
Inc. and GlaxoSmithKline. L.P. has received
investigator-initiated educational grants
from Otsuka Canada and Janssen Canada
in 2017 and a speaker fee from Otsuka
Canada in 2017 and Canadian Psychiatric
Association in 2018.

Funding
The author(s) disclosed receipt of the following financial support for the research,
authorship, and/or publication of this article: This work was funded by CIHR
Foundation Grant (375104/2017) and the
Tanna Schulich Endowment Chair.

ORCID iD
Lena Palaniyappan
0000-0003-1640-7182

https://orcid.org/

References
Anderson KK, Norman R, MacDougall A, et al.
(2018) Effectiveness of early psychosis intervention: Comparison of service users and nonusers
in population-based health administrative data.
American Journal of Psychiatry 175: 443–452.
Drake RJ, Husain N, Marshall M, et al. (2020) Effect
of delaying treatment of first-episode psychosis on symptoms and social outcomes: A
longitudinal analysis and modelling study. The
Lancet Psychiatry 7: 602–610.
Ho B-C, Andreasen NC, Ziebell S, et al. (2011) Longterm antipsychotic treatment and brain volumes:
A longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68: 128–137.
Lieberman JA, Small SA and Girgis RR (2019)
Early detection and preventive intervention
in schizophrenia: From fantasy to reality.
American Journal of Psychiatry 176: 794–810.
Malhi GS, Bell E, Hamilton A, Morris G (2021)
Early intervention for risk syndromes: what
are the real risks? Schizophrenia Research 227:
4–9.
Malhi GS, Bell E, Hamilton A, et al. (2020) Early
intervention: Lacks benefit because of lax definition? Australian and New Zealand Journal of
Psychiatry 54: 1056–1058.
Malhi GS, Morris G, Hamilton A, et al. (2017) Is
‘early intervention’ in bipolar disorder what
it claims to be? Bipolar Disorders 19: 627–636.
Mei C, Nelson B, Hartmann J, et al. (2020)
Transdiagnostic early intervention, prevention, and prediction in psychiatry. In: Baune
BT (ed.) Personalized Psychiatry. San Diego,
CA: Academic Press, pp. 27–37.
Murray RM, Quattrone D, Natesan S, et al. (2016)
Should psychiatrists be more cautious about
the long-term prophylactic use of antipsychotics? British Journal of Psychiatry 209: 361–365.
Palaniyappan L (2017) Progressive cortical reorganisation: A framework for investigating structural changes in schizophrenia. Neuroscience
and Biobehavioral Reviews 79: 1–13.
Palaniyappan L and Krishnadas R (2020) Treatment
delay in early psychosis: Not a linear problem.
The Lancet Psychiatry 7: 563–565.
Palaniyappan L and Sukumar N (2020) Reconsidering
brain tissue changes as a mechanistic focus
for early intervention in psychiatry. Journal of
Psychiatry & Neuroscience 45: 373–378.
Shah JL, Scott J, McGorry PD, et al. (2020)
Transdiagnostic clinical staging in youth mental health: A first international consensus
statement. World Psychiatry 19: 233–242.
Woods SW, Bearden CE, Sabb FW, et al. (2020)
Counterpoint: Early intervention for psychosis
risk syndromes: Minimizing risk and maximizing benefit. Schizophrenia Research 227: 10–17.
Zipursky RB, Reilly TJ and Murray RM (2013) The
myth of schizophrenia as a progressive brain
disease. Schizophrenia Bulletin 39: 1363–1372.

Australian & New Zealand Journal of Psychiatry, 55(10)

